ArticleFrontiers in pharmacology2022

Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study.

Xiang Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.